nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—Peripheral vascular disorder—Varenicline—nicotine dependence	0.0178	0.0216	CcSEcCtD
Mycophenolate mofetil—Urine abnormality—Varenicline—nicotine dependence	0.0157	0.0191	CcSEcCtD
Mycophenolate mofetil—Hostility—Varenicline—nicotine dependence	0.0157	0.0191	CcSEcCtD
Mycophenolate mofetil—Osteoporosis—Varenicline—nicotine dependence	0.0155	0.0189	CcSEcCtD
Mycophenolate mofetil—Gastric ulcer—Varenicline—nicotine dependence	0.015	0.0182	CcSEcCtD
Mycophenolate mofetil—Urine analysis abnormal—Varenicline—nicotine dependence	0.0148	0.018	CcSEcCtD
Mycophenolate mofetil—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.0133	0.0162	CcSEcCtD
Mycophenolate mofetil—Cyst—Varenicline—nicotine dependence	0.013	0.0158	CcSEcCtD
Mycophenolate mofetil—Paranoia—Varenicline—nicotine dependence	0.0128	0.0155	CcSEcCtD
Mycophenolate mofetil—Haematemesis—Varenicline—nicotine dependence	0.0125	0.0152	CcSEcCtD
Mycophenolate mofetil—Delusion—Varenicline—nicotine dependence	0.0123	0.015	CcSEcCtD
Mycophenolate mofetil—Thrombosis—Varenicline—nicotine dependence	0.0123	0.015	CcSEcCtD
Mycophenolate mofetil—Nystagmus—Varenicline—nicotine dependence	0.0122	0.0148	CcSEcCtD
Mycophenolate mofetil—Hyperlipidaemia—Varenicline—nicotine dependence	0.0121	0.0147	CcSEcCtD
Mycophenolate mofetil—Mania—Varenicline—nicotine dependence	0.012	0.0146	CcSEcCtD
Mycophenolate mofetil—Fungal infection—Varenicline—nicotine dependence	0.0113	0.0137	CcSEcCtD
Mycophenolate mofetil—Gingivitis—Varenicline—nicotine dependence	0.0111	0.0135	CcSEcCtD
Mycophenolate mofetil—Acne—Varenicline—nicotine dependence	0.0104	0.0126	CcSEcCtD
Mycophenolate mofetil—Accidental injury—Varenicline—nicotine dependence	0.00985	0.012	CcSEcCtD
Mycophenolate mofetil—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00964	0.0117	CcSEcCtD
Mycophenolate mofetil—Thinking abnormal—Varenicline—nicotine dependence	0.00952	0.0116	CcSEcCtD
Mycophenolate mofetil—Nocturia—Varenicline—nicotine dependence	0.00939	0.0114	CcSEcCtD
Mycophenolate mofetil—Leukocytosis—Varenicline—nicotine dependence	0.00927	0.0113	CcSEcCtD
Mycophenolate mofetil—Pulmonary embolism—Varenicline—nicotine dependence	0.00871	0.0106	CcSEcCtD
Mycophenolate mofetil—IMPDH2—cardiovascular system—nicotine dependence	0.00861	0.125	CbGeAlD
Mycophenolate mofetil—Eructation—Varenicline—nicotine dependence	0.00856	0.0104	CcSEcCtD
Mycophenolate mofetil—Hyperkalaemia—Varenicline—nicotine dependence	0.00856	0.0104	CcSEcCtD
Mycophenolate mofetil—Photophobia—Varenicline—nicotine dependence	0.00818	0.00994	CcSEcCtD
Mycophenolate mofetil—Oesophagitis—Varenicline—nicotine dependence	0.00796	0.00967	CcSEcCtD
Mycophenolate mofetil—Mouth ulceration—Varenicline—nicotine dependence	0.00788	0.00957	CcSEcCtD
Mycophenolate mofetil—CES2—cardiovascular system—nicotine dependence	0.00783	0.114	CbGeAlD
Mycophenolate mofetil—Hypertonia—Varenicline—nicotine dependence	0.00764	0.00928	CcSEcCtD
Mycophenolate mofetil—Mental disability—Varenicline—nicotine dependence	0.00756	0.00918	CcSEcCtD
Mycophenolate mofetil—Lymphadenopathy—Varenicline—nicotine dependence	0.00741	0.009	CcSEcCtD
Mycophenolate mofetil—Diabetes mellitus—Varenicline—nicotine dependence	0.00727	0.00883	CcSEcCtD
Mycophenolate mofetil—Deafness—Varenicline—nicotine dependence	0.00707	0.00859	CcSEcCtD
Mycophenolate mofetil—CES2—E2F transcription factor network—WASF1—nicotine dependence	0.00705	0.0654	CbGpPWpGaD
Mycophenolate mofetil—Eye pain—Varenicline—nicotine dependence	0.007	0.00851	CcSEcCtD
Mycophenolate mofetil—Injury—Varenicline—nicotine dependence	0.00688	0.00836	CcSEcCtD
Mycophenolate mofetil—Renal failure acute—Varenicline—nicotine dependence	0.00685	0.00832	CcSEcCtD
Mycophenolate mofetil—Amnesia—Varenicline—nicotine dependence	0.00673	0.00818	CcSEcCtD
Mycophenolate mofetil—IMPDH2—midbrain—nicotine dependence	0.00672	0.0976	CbGeAlD
Mycophenolate mofetil—IMPDH1—midbrain—nicotine dependence	0.00668	0.097	CbGeAlD
Mycophenolate mofetil—Atrial fibrillation—Varenicline—nicotine dependence	0.00667	0.00811	CcSEcCtD
Mycophenolate mofetil—Visual disturbance—Varenicline—nicotine dependence	0.00667	0.00811	CcSEcCtD
Mycophenolate mofetil—Thirst—Varenicline—nicotine dependence	0.00664	0.00807	CcSEcCtD
Mycophenolate mofetil—Hypoglycaemia—Varenicline—nicotine dependence	0.00648	0.00787	CcSEcCtD
Mycophenolate mofetil—Cerebrovascular accident—Varenicline—nicotine dependence	0.00645	0.00784	CcSEcCtD
Mycophenolate mofetil—CES1—cardiovascular system—nicotine dependence	0.00644	0.0935	CbGeAlD
Mycophenolate mofetil—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00639	0.0592	CbGpPWpGaD
Mycophenolate mofetil—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00632	0.00768	CcSEcCtD
Mycophenolate mofetil—Osteoarthritis—Varenicline—nicotine dependence	0.00632	0.00768	CcSEcCtD
Mycophenolate mofetil—Affect lability—Varenicline—nicotine dependence	0.00622	0.00756	CcSEcCtD
Mycophenolate mofetil—Psychotic disorder—Varenicline—nicotine dependence	0.00618	0.0075	CcSEcCtD
Mycophenolate mofetil—CES2—midbrain—nicotine dependence	0.00611	0.0887	CbGeAlD
Mycophenolate mofetil—Urinary retention—Varenicline—nicotine dependence	0.00601	0.0073	CcSEcCtD
Mycophenolate mofetil—Mood swings—Varenicline—nicotine dependence	0.00599	0.00728	CcSEcCtD
Mycophenolate mofetil—Liver function test abnormal—Varenicline—nicotine dependence	0.00584	0.00709	CcSEcCtD
Mycophenolate mofetil—Hypokalaemia—Varenicline—nicotine dependence	0.00576	0.00699	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00567	0.0526	CbGpPWpGaD
Mycophenolate mofetil—Gastritis—Varenicline—nicotine dependence	0.0056	0.0068	CcSEcCtD
Mycophenolate mofetil—Abdominal distension—Varenicline—nicotine dependence	0.0055	0.00668	CcSEcCtD
Mycophenolate mofetil—Asthma—Varenicline—nicotine dependence	0.00547	0.00664	CcSEcCtD
Mycophenolate mofetil—Dysphagia—Varenicline—nicotine dependence	0.00547	0.00664	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Biological oxidations—CYP2A7—nicotine dependence	0.00534	0.0495	CbGpPWpGaD
Mycophenolate mofetil—Angina pectoris—Varenicline—nicotine dependence	0.00532	0.00647	CcSEcCtD
Mycophenolate mofetil—UGT1A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00527	0.0489	CbGpPWpGaD
Mycophenolate mofetil—Bronchitis—Varenicline—nicotine dependence	0.00526	0.00639	CcSEcCtD
Mycophenolate mofetil—UGT1A10—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00519	0.0481	CbGpPWpGaD
Mycophenolate mofetil—Pollakiuria—Varenicline—nicotine dependence	0.00505	0.00613	CcSEcCtD
Mycophenolate mofetil—Erectile dysfunction—Varenicline—nicotine dependence	0.00503	0.00611	CcSEcCtD
Mycophenolate mofetil—Weight increased—Varenicline—nicotine dependence	0.00497	0.00604	CcSEcCtD
Mycophenolate mofetil—Hyperglycaemia—Varenicline—nicotine dependence	0.00493	0.00599	CcSEcCtD
Mycophenolate mofetil—Infestation—Varenicline—nicotine dependence	0.00487	0.00592	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Varenicline—nicotine dependence	0.00487	0.00592	CcSEcCtD
Mycophenolate mofetil—Depression—Varenicline—nicotine dependence	0.00486	0.0059	CcSEcCtD
Mycophenolate mofetil—UGT1A10—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00482	0.0447	CbGpPWpGaD
Mycophenolate mofetil—Acute coronary syndrome—Varenicline—nicotine dependence	0.0048	0.00584	CcSEcCtD
Mycophenolate mofetil—Myocardial infarction—Varenicline—nicotine dependence	0.00478	0.0058	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Varenicline—nicotine dependence	0.00475	0.00577	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Varenicline—nicotine dependence	0.00474	0.00575	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Varenicline—nicotine dependence	0.00461	0.0056	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Varenicline—nicotine dependence	0.0046	0.00558	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Varenicline—nicotine dependence	0.00457	0.00555	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00457	0.0424	CbGpPWpGaD
Mycophenolate mofetil—Bradycardia—Varenicline—nicotine dependence	0.00445	0.00541	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Varenicline—nicotine dependence	0.00435	0.00529	CcSEcCtD
Mycophenolate mofetil—Hallucination—Varenicline—nicotine dependence	0.00435	0.00529	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Varenicline—nicotine dependence	0.00432	0.00525	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Varenicline—nicotine dependence	0.00431	0.00524	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Varenicline—nicotine dependence	0.0043	0.00522	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Varenicline—nicotine dependence	0.00429	0.00521	CcSEcCtD
Mycophenolate mofetil—IMPDH2—brain—nicotine dependence	0.00422	0.0613	CbGeAlD
Mycophenolate mofetil—Visual impairment—Varenicline—nicotine dependence	0.00422	0.00512	CcSEcCtD
Mycophenolate mofetil—IMPDH1—brain—nicotine dependence	0.0042	0.0609	CbGeAlD
Mycophenolate mofetil—UGT1A8—Biological oxidations—CYP2A7—nicotine dependence	0.00416	0.0385	CbGpPWpGaD
Mycophenolate mofetil—CES1—E2F transcription factor network—WASF1—nicotine dependence	0.00416	0.0385	CbGpPWpGaD
Mycophenolate mofetil—Eye disorder—Varenicline—nicotine dependence	0.00409	0.00497	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Varenicline—nicotine dependence	0.00408	0.00495	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Varenicline—nicotine dependence	0.00406	0.00493	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Varenicline—nicotine dependence	0.00397	0.00482	CcSEcCtD
Mycophenolate mofetil—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00396	0.0367	CbGpPWpGaD
Mycophenolate mofetil—Mediastinal disorder—Varenicline—nicotine dependence	0.00394	0.00479	CcSEcCtD
Mycophenolate mofetil—Chills—Varenicline—nicotine dependence	0.00393	0.00477	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Varenicline—nicotine dependence	0.00391	0.00475	CcSEcCtD
Mycophenolate mofetil—CES2—brain—nicotine dependence	0.00384	0.0557	CbGeAlD
Mycophenolate mofetil—Mental disorder—Varenicline—nicotine dependence	0.00383	0.00466	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Varenicline—nicotine dependence	0.00381	0.00463	CcSEcCtD
Mycophenolate mofetil—Flatulence—Varenicline—nicotine dependence	0.00375	0.00456	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Varenicline—nicotine dependence	0.00373	0.00453	CcSEcCtD
Mycophenolate mofetil—Back pain—Varenicline—nicotine dependence	0.00368	0.00447	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Varenicline—nicotine dependence	0.00366	0.00445	CcSEcCtD
Mycophenolate mofetil—Tremor—Varenicline—nicotine dependence	0.00357	0.00433	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Varenicline—nicotine dependence	0.00353	0.00429	CcSEcCtD
Mycophenolate mofetil—Anaemia—Varenicline—nicotine dependence	0.00352	0.00428	CcSEcCtD
Mycophenolate mofetil—Agitation—Varenicline—nicotine dependence	0.0035	0.00425	CcSEcCtD
Mycophenolate mofetil—Angioedema—Varenicline—nicotine dependence	0.00348	0.00423	CcSEcCtD
Mycophenolate mofetil—Malaise—Varenicline—nicotine dependence	0.00343	0.00417	CcSEcCtD
Mycophenolate mofetil—Vertigo—Varenicline—nicotine dependence	0.00342	0.00416	CcSEcCtD
Mycophenolate mofetil—Syncope—Varenicline—nicotine dependence	0.00342	0.00415	CcSEcCtD
Mycophenolate mofetil—Palpitations—Varenicline—nicotine dependence	0.00337	0.00409	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Varenicline—nicotine dependence	0.00335	0.00407	CcSEcCtD
Mycophenolate mofetil—Cough—Varenicline—nicotine dependence	0.00332	0.00404	CcSEcCtD
Mycophenolate mofetil—Convulsion—Varenicline—nicotine dependence	0.0033	0.00401	CcSEcCtD
Mycophenolate mofetil—Hypertension—Varenicline—nicotine dependence	0.00329	0.00399	CcSEcCtD
Mycophenolate mofetil—Chest pain—Varenicline—nicotine dependence	0.00324	0.00394	CcSEcCtD
Mycophenolate mofetil—Myalgia—Varenicline—nicotine dependence	0.00324	0.00394	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Varenicline—nicotine dependence	0.00324	0.00394	CcSEcCtD
Mycophenolate mofetil—Anxiety—Varenicline—nicotine dependence	0.00323	0.00392	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00322	0.00391	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00322	0.0298	CbGpPWpGaD
Mycophenolate mofetil—Discomfort—Varenicline—nicotine dependence	0.0032	0.00389	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Varenicline—nicotine dependence	0.00317	0.00385	CcSEcCtD
Mycophenolate mofetil—CES1—brain—nicotine dependence	0.00316	0.0459	CbGeAlD
Mycophenolate mofetil—Oedema—Varenicline—nicotine dependence	0.00311	0.00378	CcSEcCtD
Mycophenolate mofetil—Infection—Varenicline—nicotine dependence	0.00309	0.00375	CcSEcCtD
Mycophenolate mofetil—Shock—Varenicline—nicotine dependence	0.00306	0.00371	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Varenicline—nicotine dependence	0.00305	0.0037	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Varenicline—nicotine dependence	0.00304	0.0037	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Varenicline—nicotine dependence	0.00303	0.00368	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Biological oxidations—CYP2A7—nicotine dependence	0.00303	0.0281	CbGpPWpGaD
Mycophenolate mofetil—Skin disorder—Varenicline—nicotine dependence	0.00302	0.00367	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Varenicline—nicotine dependence	0.003	0.00365	CcSEcCtD
Mycophenolate mofetil—UGT1A6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00299	0.0277	CbGpPWpGaD
Mycophenolate mofetil—Anorexia—Varenicline—nicotine dependence	0.00296	0.0036	CcSEcCtD
Mycophenolate mofetil—Hypotension—Varenicline—nicotine dependence	0.0029	0.00353	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00283	0.00344	CcSEcCtD
Mycophenolate mofetil—Insomnia—Varenicline—nicotine dependence	0.00281	0.00341	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Varenicline—nicotine dependence	0.00277	0.00337	CcSEcCtD
Mycophenolate mofetil—Somnolence—Varenicline—nicotine dependence	0.00276	0.00336	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Varenicline—nicotine dependence	0.00274	0.00332	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Varenicline—nicotine dependence	0.0027	0.00328	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00268	0.00326	CcSEcCtD
Mycophenolate mofetil—Constipation—Varenicline—nicotine dependence	0.00266	0.00323	CcSEcCtD
Mycophenolate mofetil—Pain—Varenicline—nicotine dependence	0.00266	0.00323	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Varenicline—nicotine dependence	0.00256	0.00311	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Varenicline—nicotine dependence	0.00254	0.00309	CcSEcCtD
Mycophenolate mofetil—Urticaria—Varenicline—nicotine dependence	0.00247	0.003	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Varenicline—nicotine dependence	0.00246	0.00298	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Varenicline—nicotine dependence	0.00246	0.00298	CcSEcCtD
Mycophenolate mofetil—ABCG2—midbrain—nicotine dependence	0.00239	0.0347	CbGeAlD
Mycophenolate mofetil—Hypersensitivity—Varenicline—nicotine dependence	0.00229	0.00278	CcSEcCtD
Mycophenolate mofetil—Asthenia—Varenicline—nicotine dependence	0.00223	0.00271	CcSEcCtD
Mycophenolate mofetil—Pruritus—Varenicline—nicotine dependence	0.0022	0.00267	CcSEcCtD
Mycophenolate mofetil—ALB—brain—nicotine dependence	0.0022	0.0319	CbGeAlD
Mycophenolate mofetil—Diarrhoea—Varenicline—nicotine dependence	0.00213	0.00258	CcSEcCtD
Mycophenolate mofetil—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00213	0.0197	CbGpPWpGaD
Mycophenolate mofetil—Dizziness—Varenicline—nicotine dependence	0.00206	0.0025	CcSEcCtD
Mycophenolate mofetil—Vomiting—Varenicline—nicotine dependence	0.00198	0.0024	CcSEcCtD
Mycophenolate mofetil—Rash—Varenicline—nicotine dependence	0.00196	0.00238	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Varenicline—nicotine dependence	0.00196	0.00238	CcSEcCtD
Mycophenolate mofetil—Headache—Varenicline—nicotine dependence	0.00195	0.00237	CcSEcCtD
Mycophenolate mofetil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0019	0.0176	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00187	0.0174	CbGpPWpGaD
Mycophenolate mofetil—Nausea—Varenicline—nicotine dependence	0.00185	0.00224	CcSEcCtD
Mycophenolate mofetil—UGT2B7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00176	0.0163	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Biological oxidations—CYP2A7—nicotine dependence	0.00165	0.0153	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00164	0.0152	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00163	0.0151	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00162	0.015	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—brain—nicotine dependence	0.00154	0.0224	CbGeAlD
Mycophenolate mofetil—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00154	0.0143	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—cardiovascular system—nicotine dependence	0.00151	0.0219	CbGeAlD
Mycophenolate mofetil—ABCG2—brain—nicotine dependence	0.0015	0.0218	CbGeAlD
Mycophenolate mofetil—UGT1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00143	0.0132	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00143	0.0132	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00134	0.0125	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Biological oxidations—CYP2A7—nicotine dependence	0.00134	0.0125	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00133	0.0124	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00133	0.0123	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00133	0.0123	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—midbrain—nicotine dependence	0.00118	0.0171	CbGeAlD
Mycophenolate mofetil—IMPDH2—Metabolism—CYP2A7—nicotine dependence	0.00103	0.00951	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—CYP2A7—nicotine dependence	0.000914	0.00847	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000883	0.00818	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000871	0.00807	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000867	0.00804	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—CYP2A7—nicotine dependence	0.000836	0.00775	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000817	0.00758	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000806	0.00747	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000751	0.00696	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—brain—nicotine dependence	0.000741	0.0108	CbGeAlD
Mycophenolate mofetil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000715	0.00663	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—CYP2A7—nicotine dependence	0.000711	0.00659	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000708	0.00656	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000698	0.00647	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00067	0.00621	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—CYP2A7—nicotine dependence	0.000519	0.00481	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000479	0.00444	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00045	0.00417	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000417	0.00386	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000403	0.00374	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00038	0.00352	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000375	0.00347	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CYP2A7—nicotine dependence	0.000314	0.00291	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CYP2A7—nicotine dependence	0.000283	0.00262	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000257	0.00238	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP2A7—nicotine dependence	0.00023	0.00213	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP2A7—nicotine dependence	0.00023	0.00213	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000225	0.00209	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP2A7—nicotine dependence	0.000211	0.00195	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.000195	0.00181	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.00014	0.0013	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.000121	0.00112	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP2A7—nicotine dependence	0.00012	0.00112	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000105	0.000978	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP2A7—nicotine dependence	6.5e-05	0.000602	CbGpPWpGaD
